Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia
Crossref DOI link: https://doi.org/10.1007/s12020-016-0939-0
Published Online: 2016-04-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ferri, Nicola
Ruscica, Massimiliano
Funding for this research was provided by:
Fondazione Cariplo (2015-0552)
Fondazione Cariplo (2012-0549)
Text and Data Mining valid from 2016-04-01